All Stories

  1. New Insights into the Role of FGF-23 and Klotho in Cardiovascular Disease in Chronic Kidney Disease Patients

    Article • Current Vascular Pharmacology, December 2020, Bentham Science Publishers

    MD, PhD, FERA Aikaterini Papagianni

  2. Fibroblast Growth Factor-23: A Novel Biomarker for Cardiovascular Disease in Chronic Kidney Disease Patients

    Article • PRILOZI, January 2017, De Gruyter

    MD, PhD, FERA Aikaterini Papagianni